Form 4 for RARE Ultragenyx Pharmaceutical Inc.
Accepted 2026-02-03 00:00:00 ET · period of report 2026-02-02 · accession 0001193125-26-034832 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-02-03 | 2026-02-02 | RARE | Horn Howard | CFO | S - Sale | $23.56 | -3,061 | 88.9K | -3% | -$72.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-02 | S | D | 3,061 | $23.56 | 88,935 | D | — | — | (F1) Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. |